Adicon Holdings Sees Nearly 7% Gain on Deep Strategic Partnership with Gobi Medical Group

Stock News03-16

Adicon Holdings (09860) closed up nearly 7%, rising 6.73% to HK$4.76 by the market close, with a turnover of HK$1.562 million. Earlier this month, the company formally entered into a strategic cooperation agreement with Gobi Medical Group. The two parties will establish a long-term, stable strategic partnership, focusing on diversified collaboration in areas such as medical and scientific research services, joint development platform construction, IT data coordination, and discipline development and talent cultivation. This strategic collaboration between Adicon and Gobi Medical Group represents a significant cross-sector integration between a third-party medical testing institution and a research-focused medical group, and is a key step for Adicon in deepening its integrated development path of "technology + service + ecosystem." Notably, following the full digestion of negative factors and the potential return of capital, Adicon Holdings is expected to begin a valuation recovery. In November 2025, Adicon Holdings announced the acquisition of Crown Bioscience for US$204 million. Its comparable company, BioMap, currently has a market capitalization of nearly HK$26 billion, indicating that Adicon's current market value does not fully reflect its reasonable valuation, leaving ample room for upward adjustment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155120912?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 16:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155120912","market":"other","top_or_hot":-1,"title":"Adicon Holdings Sees Nearly 7% Gain on Deep Strategic Partnership with Gobi Medical Group","media":"Stock News","content":"<p>Adicon Holdings (09860) closed up nearly 7%, rising 6.73% to HK$4.76 by the market close, with a turnover of HK$1.562 million. Earlier this month, the company formally entered into a strategic cooperation agreement with Gobi Medical Group. The two parties will establish a long-term, stable strategic partnership, focusing on diversified collaboration in areas such as medical and scientific research services, joint development platform construction, IT data coordination, and discipline development and talent cultivation. This strategic collaboration between Adicon and Gobi Medical Group represents a significant cross-sector integration between a third-party medical testing institution and a research-focused medical group, and is a key step for Adicon in deepening its integrated development path of \"technology + service + ecosystem.\" Notably, following the full digestion of negative factors and the potential return of capital, Adicon Holdings is expected to begin a valuation recovery. In November 2025, Adicon Holdings announced the acquisition of Crown Bioscience for US$204 million. Its comparable company, BioMap, currently has a market capitalization of nearly HK$26 billion, indicating that Adicon's current market value does not fully reflect its reasonable valuation, leaving ample room for upward adjustment.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adicon Holdings Sees Nearly 7% Gain on Deep Strategic Partnership with Gobi Medical Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdicon Holdings Sees Nearly 7% Gain on Deep Strategic Partnership with Gobi Medical Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-16 16:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Adicon Holdings (09860) closed up nearly 7%, rising 6.73% to HK$4.76 by the market close, with a turnover of HK$1.562 million. Earlier this month, the company formally entered into a strategic cooperation agreement with Gobi Medical Group. The two parties will establish a long-term, stable strategic partnership, focusing on diversified collaboration in areas such as medical and scientific research services, joint development platform construction, IT data coordination, and discipline development and talent cultivation. This strategic collaboration between Adicon and Gobi Medical Group represents a significant cross-sector integration between a third-party medical testing institution and a research-focused medical group, and is a key step for Adicon in deepening its integrated development path of \"technology + service + ecosystem.\" Notably, following the full digestion of negative factors and the potential return of capital, Adicon Holdings is expected to begin a valuation recovery. In November 2025, Adicon Holdings announced the acquisition of Crown Bioscience for US$204 million. Its comparable company, BioMap, currently has a market capitalization of nearly HK$26 billion, indicating that Adicon's current market value does not fully reflect its reasonable valuation, leaving ample room for upward adjustment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VXUS","symbol_name":"国际股票ETF-Vanguard","start_time":0,"source_url":"","article_id":"1155120912","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155120912","pubTimestamp":1773649111,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Adicon Holdings (09860) closed up nearly 7%, rising 6.73% to HK$4.76 by the market close, with a turnover of HK$1.562 million. Earlier this month, the company formally entered into a strategic...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","VXUS":"国际股票ETF-Vanguard","BK1219":"保健护理服务","BK4588":"碎股","09860":"艾迪康控股","BK4585":"ETF&股票定投概念"},"translate_title":"艾迪康控股与戈壁医疗集团深度战略合作，股价上涨近7%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"VXUS":1,"09860":1},"content_text":"Adicon Holdings (09860) closed up nearly 7%, rising 6.73% to HK$4.76 by the market close, with a turnover of HK$1.562 million. Earlier this month, the company formally entered into a strategic cooperation agreement with Gobi Medical Group. The two parties will establish a long-term, stable strategic partnership, focusing on diversified collaboration in areas such as medical and scientific research services, joint development platform construction, IT data coordination, and discipline development and talent cultivation. This strategic collaboration between Adicon and Gobi Medical Group represents a significant cross-sector integration between a third-party medical testing institution and a research-focused medical group, and is a key step for Adicon in deepening its integrated development path of \"technology + service + ecosystem.\" Notably, following the full digestion of negative factors and the potential return of capital, Adicon Holdings is expected to begin a valuation recovery. In November 2025, Adicon Holdings announced the acquisition of Crown Bioscience for US$204 million. Its comparable company, BioMap, currently has a market capitalization of nearly HK$26 billion, indicating that Adicon's current market value does not fully reflect its reasonable valuation, leaving ample room for upward adjustment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155120912","isCrawlerRequest":true}